EXCISION BIOTHERAPEUTICS
Excision BioTherapeutics is a private company focused on developing advanced gene-editing therapeutics to address the medical need for the treatment of life-threatening diseases caused by viral infections. They develop gene-editing medicines that eradicate or disrupt viral genes in human patients. Their mission is to advance gene-editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
EXCISION BIOTHERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.excision.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
70.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail PHP
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
AmideBio
AmideBio develops and commercializes peptide research reagents and clinical products for clinical and therapeutic marketplaces.
Amplo Biotechnology
Amplo Biotechnology is to develop multiple, potentially curative, Adeno-Associated Viral (AAV) therapies for the neuromuscular junction.
Amyloid Solution
Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments.
Apton Biosystems
Apton Biosystems develops an optical system designed for sequencing and protein detection.
Arvinas
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
BioAegis Therapeutics
BioAegis is developing therapeutics for infectious, inflammatory and degenerative diseases based on the platform of plasma gelsolin.
BIOMx
BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Elstar Therapeutics
Fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating multi-functional therapeutics.
HepaTx
Hepatx is developing regenerative medicine solutions.
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
InGeneron
InGeneron enables novel, safe, and evidence-based therapies that unlock the healing potential of each patient's own regenerative cells.
Inspire Medical Systems
Inspire Medical Systems develops implantable therapeutic devices for the treatment of obstructive sleep apnea.
Kineta
Kineta aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.
Laronde
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
Nanoscope Therapeutics
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight.
NonExomics
NonExomics develops therapeutics to diagnose and cure diseases emanating from the nonexome.
PathoQuest
PathoQuest is a biotech company developing NGS-based metagenomic tests for exhaustive identification of pathogens.
Precision Biologics
Precision Biologics develops therapeutic and diagnostic products for the early detection and treatment of cancer.
Precision Biopsy
Precision Biopsy is a startup commercializing optical biopsy technologies that improve prostate biopsies and diagnostics.
QUE Oncology
QUE Oncology develops novel therapies to address unmet medical needs in the treatment of cancer and its consequences.
RenovoRx
RenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system.
Rodin Therapeutics
Rodin Therapeutics develops novel therapeutics for neurological disorders by applying insights of epigenetics.
Scioto Biosciences
Scioto is a developer of Activated Bacterial Therapeutics platform.
SteadyMed Therapeutics
SteadyMed is a media-device company developing injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.
USMD
USMD Holdings develops, operates and manages entities that deliver diagnostic, therapeutic and hospital-based health care to patients.
Vasomune
Vasomune Therapeutics is a biotechnology company, developing therapies for blood vessel diseases - vascular dysfunction and destabilization.
Vaxess Technologies
Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
Zavante Therapeutics
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
Zebra Biologics
Zebra Biologics develops bio superior agonist and antagonist antibody therapeutics for many diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cota Capital
Cota Capital investment in Venture Round - Excision BioTherapeutics
Loreda Holdings
Loreda Holdings investment in Venture Round - Excision BioTherapeutics
Olive Tree Capital
Olive Tree Capital investment in Venture Round - Excision BioTherapeutics
Anzu Partners
Anzu Partners investment in Venture Round - Excision BioTherapeutics
IndusAge Partners
IndusAge Partners investment in Venture Round - Excision BioTherapeutics
Adjuvant Capital
Adjuvant Capital investment in Venture Round - Excision BioTherapeutics
GreatPoint Ventures
GreatPoint Ventures investment in Venture Round - Excision BioTherapeutics
Artis Ventures (AV)
Artis Ventures (AV) investment in Venture Round - Excision BioTherapeutics
Celesta Capital
Celesta Capital investment in Venture Round - Excision BioTherapeutics
Norwest Venture Partners
Norwest Venture Partners investment in Venture Round - Excision BioTherapeutics
Official Site Inspections
http://www.excision.bio Semrush global rank: 4.94 M Semrush visits lastest month: 1.73 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Excision BioTherapeutics"
About - Excision BioTherapeutics, Inc.
Located in Watertown, MA, Excision BioTherapeutics, Inc. is a biotechnology company developing CRISPR-based therapies intended for the treatment of viral infectious diseases. We are focused on improving the lives of chronically ill …See details»
Excision BioTherapeutics - Wikipedia
Excision BioTherapeutics is a biopharmaceutical company based in San Francisco focused on developing gene therapies against HIV infection. The company has a single, CRISPR–Cas9 based therapy, EBT-101, under investigation. Initial investigation into the therapy was conducted by the lab of Kamel Khalili, a professor at Temple University. In July, 2023 the US Food and Drug Administration granted EBT-101 fast-track status. …See details»
Excision BioTherapeutics - Crunchbase Company …
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients. Search Crunchbase. ... 9,467 Number of Organizations • $1.9T Total Funding Amount • 102,348 Number of …See details»
Leadership Team - Excision BioTherapeutics, Inc.
Jennifer Gordon, Ph.D. Chief Scientific Officer. Jennifer Gordon, Ph.D. is Chief Scientific Officer at Excision BioTherapeutics. Prior to joining Excision, Dr. Gordon spent nearly three decades in …See details»
Excision BioTherapeutics - LinkedIn
Excision BioTherapeutics | 4,676 followers on LinkedIn. Developing CRISPR-based therapies intended to cure viral infectious diseases. | Excision BioTherapeutics is a private company focused on ...See details»
Excision BioTherapeutics - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... 2020 BIO Investor Forum Buzz …See details»
Excision BioTherapeutics Completes $60 Million Financing to …
Feb 17, 2021 Financing will support advancement of lead HIV potential cure program into clinical developmentSAN FRANCISCO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Excision …See details»
CRISPR-Focused Excision BioTherapeutics Announces Business …
Nov 3, 2020 First members include industry veterans with backgrounds at Merck, Pfizer, Novartis, and moreSAN FRANCISCO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Excision …See details»
Excision BioTherapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Company: Excision BioTherapeutics - CRISPR Medicine
Excsision BioTherapeutics is a start-up gene-editing company focused on curing viral infections with CRISPR. The company has developed a proprietary technolegy where dual gRNAs …See details»
CRISPR-Focused Excision BioTherapeutics Announces Business
Nov 3, 2020 Excision BioTherapeutics, Inc., a biotechnology company developing CRISPR-based therapies to cure viral infectious diseases. Excision is focused on improving the lives of …See details»
Excision Company Profile 2024: Valuation, Funding & Investors
Excision General Information Description. Developer of medical gene editing therapeutics designed to assist in the treatment of neurotrophic viruses. The company's curative therapies …See details»
Excision BioTherapeutics to Present at Upcoming Conferences
SAN FRANCISCO, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Excision BioTherapeutics Inc., a clinical-stage biotechnology company developing CRISPR-based therapies intended to cure …See details»
Excision BioTherapeutics Completes $60 Million Financing to
Feb 17, 2021 For more information, please visit www.excision.bio. Editor’s Note: Kamel Khalili is Co-Founder and Chief Scientific Consultant, and holds equity in Excision Biotherapeutics, …See details»
Excision Team :: Excision BioTherapeutics, Inc.
Jennifer Gordon, Ph.D. Chief Scientific Officer. Jennifer Gordon, Ph.D. is Chief Scientific Officer at Excision BioTherapeutics. Prior to joining Excision, Dr. Gordon spent nearly three decades in …See details»
Business Advisory Board :: Excision BioTherapeutics, Inc.
He currently serves on the Boards of Equillium LLC, a clinical-stage biotechnology company, the Foundation for Defense of Democracies, a non-profit policy institute focusing on foreign policy …See details»
Excision BioTherapeutics Expands Management Team with Three …
Oct 12, 2021 Sara Turken, J.D., as General CounselManish Anand, M.Sc., as Senior Vice President, Regulatory AffairsRobert Gunning, CPA, CGMA, as VP, Controller SAN …See details»
New Data from Excision Bio : r/HerpesCureAdvocates - Reddit
HCA is a grassroots, international advocacy organization with a goal of treatment, prevention, and cure for Herpes Simplex Virus types 1 + 2. www.herpescureadvocacy.com Members Online • …See details»
Publications - Excision BioTherapeutics, Inc.
Excision’s library of publications provides information on the research behind our novel CRISPR gene-editing technology and discovery platform. Future of CRISPR: Gene Editing …See details»